Comparison of gadodiamide‐enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of renal artery stenosis: Results of a phase III multicenter trial
- 23 January 2010
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 31 (2) , 390-397
Abstract
Purpose: To evaluate the efficacy and safety of 0.1 mmol/kg gadodiamide administration for contrast‐enhanced magnetic resonance angiography (MRA) in detecting hemodynamically relevant renal artery stenosis (RAS) when compared with intraarterial digital subtraction angiography (IA‐DSA) as the gold standard.Materials and Methods: In a multicenter, controlled study, 395 patients with suspected or known RAS were included. Three independent readers evaluated the MRA images. Two readers evaluated the IA‐DSA images and subsequently achieved consensus. The sensitivities and specificities of gadodiamide‐enhanced MRA were analyzed at the per‐patient and per‐vessel levels (exact 1‐sided binomial test at α = 0.025 with 95% confidence interval).Results: A total of 335 patients who had available standard of truth and MRA tests were included in the all‐subjects efficacy population: 55.5% (186/335) men and 44.5% women with a mean age of 63 ± 13 years (range 17–85 years). The sensitivities and specificities ranged from 81% to 86% for all independent readers at the per‐patient analysis based on subjects with the diagnostic images. Similar results were achieved with per‐vessel level analysis. Fewer than 1% of patients had adverse event associated with gadodiamide administration. There were no cases of nephrogenic systemic fibrosis (NSF) reported.Conclusion: Gadodiamide administration at the labeled dose of 0.1 mmol/kg for contrast‐enhanced MRA achieved equivalent results compared to IA‐DSA in evaluation of RAS and was well tolerated. J. Magn. Reson. Imaging 2010; 31: 390–397.Keywords
This publication has 24 references indexed in Scilit:
- Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical CentersRadiology, 2008
- Impact on Hospital Policy: Yale ExperienceJournal of the American College of Radiology, 2008
- Technology Insight: clinical role of magnetic resonance angiography in the diagnosis and management of renal artery stenosisNature Clinical Practice Cardiovascular Medicine, 2006
- Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?Nephrology Dialysis Transplantation, 2006
- Assessment of Gadolinium-Enhanced Time-Resolved Three-Dimensional MR Angiography for Evaluating Renal Artery StenosisAmerican Journal of Roentgenology, 2001
- The Effect of Balloon Angioplasty on Hypertension in Atherosclerotic Renal-Artery StenosisNew England Journal of Medicine, 2000
- Diagnosis of Renal Vascular Disease with MR AngiographyRadioGraphics, 1999
- Renal Arteries1999
- Iliac artery stenosis measurements: comparison of two-dimensional time-of-flight and three-dimensional dynamic gadolinium-enhanced MR angiography.American Journal of Roentgenology, 1997
- Dynamic gadolinium‐enhanced three‐dimensional abdominal MR arteriographyJournal of Magnetic Resonance Imaging, 1993